PR
Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.
Press Report
-
2019.06.26First licensed stem cell thera..First licensed stem cell therapy for ALSCORESTEM launched th..
-
2019.05.27Corestem applies for FDA meet ..Corestem applies for FDA meet on Lou Gehrig's drugCorestem s..
-
2018.11.01Paper of the month: Intratheca..Paper of the month: Intrathecal stem cells for amyotrophic l..
-
2017.02.16'Troublemaker Doctor' out of t..Korea's Bio Industry: Voices of the field ④ CORESTEM and CEO..
- 24, Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
- Gen (02) 497-3711
- IR DID 070-4706-3546
- FAX (02) 6349-8666
- E-MAIL corestem@corestem.com
Copyright 2018 CORESTEM, Inc All right reserved.
